SENSEX
NIFTY
GOLD
USD/INR

Weather

image 38    C

Economy News

The Economic Times

Economy / The Economic Times

details

Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic move, expected to conclude by June 2026, will bolster Aurobindo's complex generics and controlled substances portfolio, enhance its US manufacturing capabilities with Lannett's Indiana facility, and is projected to immediately boost earnings per share.

22 Jun 2026 8:46 am